Summit Therapeutics Inc. (SMMT)
$12.73-3.27%Close
SELLCRISIS · day 7
Key stats
Short interest · FINRA settlement 2026-07-31
52-week IV39.8%–289.1%
- Market cap
- $9.9B
- Avg volume
- 5.2M
- Beta
- -1.24
- P/E (TTM)
- -11.37
- IV-%ile
- 51
- IV ATM
- 88.8%
- Short % float
- 33.76%
- Days to cover
- 8.9
- SI change
- -2.9%
- 1W
- -0.39%
- 1M
- -6.81%
- 3M
- -23.41%
- YTD
- -27.34%
- vs SPY 1W
- +0.80%
- vs SPY 1M
- -10.13%
- vs SPY 3M
- -25.80%
- vs SPY YTD
- -39.09%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- ANIXBUYAnixa Biosciences, Inc.RECOVERYQ 6$3.62-2.43%
- ANROBUYAlto Neuroscience, Inc.BULLQ 27$36.25+5.75%
- CRBPBUYCorbus Pharmaceuticals Holdings, Inc.RECOVERYQ 6$10.69+2.99%
- CRDLBUYCardiol Therapeutics Inc.RECOVERYQ 4$1.86+0.00%
- CTNMBUYContineum Therapeutics, Inc. Class A Common StockRECOVERYQ 13$16.63-3.26%
- NBPBUYNovaBridge BiosciencesRECOVERYQ -4$1.89-5.50%
- NGNEBUYNeurogene Inc.RECOVERYQ 8$39.64+2.61%
- SGMTBUYSagimet Biosciences Inc.BULLQ 8$10.21-0.39%
- SLDBSELLSolid Biosciences Inc.RECOVERYQ -12$9.16-1.51%
- ABVXSELLAbivax S.A.BEARQ 61$116.15+1.04%
- ANNXSELLAnnexon, Inc.RECOVERYQ -7$5.06-0.20%
- CABABUYCabaletta Bio, Inc.RECOVERYQ -3$3.10-0.96%
Industry peers
FMP comparable companies · ranked by market cap
- MRNABUYModerna, Inc.$55.1BRECOVERYQ 29$138.89-4.30%
- RVMDBUYRevolution Medicines, Inc.$45.0BBULLQ 31$211.58+1.01%
- RPRXBUYRoyalty Pharma plc$27.2BBULLQ 12$61.33+0.03%
- ROIVBUYRoivant Sciences Ltd.$26.3BBULLQ 31$36.36+0.17%
- EXASExact Sciences Corporation$20.0B$104.91
- BBIOSELLBridgeBio Pharma, Inc.$15.9BRECOVERYQ 20$81.07-0.53%
- ASNDSELLAscendis Pharma A/S$15.6BRECOVERYQ 37$251.95-0.53%
- UHSBUYUniversal Health Services, Inc.$10.7BRECOVERYQ 16$176.40-0.49%
- IONSBUYIonis Pharmaceuticals, Inc.$10.3BRECOVERYQ 9$62.04+3.85%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 18
- VALUE
- 7
- GROWTH
- 47
- GARP
- 5
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-122.6%
REV YoY-
ROE-204.3%
EPS YoY-
ROA-113.8%
GROSS0
OP0
NET0
[VALUATION]
P/E TTM-11.37
P/E FWD-
SECTOR PE22.66
INDUSTRY PE17.07
P/B15.72
P/FCF-
EV/EBITDA-11.40
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E3.24
ALTMAN Z-
CURR RATIO6.96
ND/EBITDA-
BETA-1.24
